pentoxifylline has been researched along with Pulmonary Sarcoidosis in 8 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pentoxifylline (POF) has recently been shown to suppress the cytokine production from lipopolysaccharide (LPS) stimulated monocytes/alveolar macrophages (AM)." | 5.32 | [Inhibition of cytokine release from alveolar macrophages in pulmonary sarcoidosis by pentoxifylline]. ( Chen, BM; Costabel, U; Dai, HP; Guzman, J; Tong, ZH; Wang, C, 2003) |
| "Pentoxifylline (POF) has been shown to suppress the cytokine production from lipopolysaccharide (LPS)-stimulated monocytes/alveolar macrophages (AMs)." | 5.32 | Inhibition of cytokine release from alveolar macrophages in pulmonary sarcoidosis by pentoxifylline: comparison with dexamethasone. ( Abdoh, Z; Chen, B; Costabel, U; Dai, H; Guzman, J; Tong, Z, 2003) |
| " Because tumor necrosis factor alpha (TNF) plays a critical role in granuloma formation and sustenance as well as in the progression of sarcoidosis, we investigated pentoxifylline (POF), which exerts TNF-inhibitory activity, as a therapeutic agent in active pulmonary sarcoidosis." | 3.69 | Pentoxifylline in treatment of sarcoidosis. ( Dalhoff, K; Entzian, P; Schlaak, M; Zabel, P, 1997) |
| "Pentoxifylline (POF) has recently been shown to suppress the cytokine production from lipopolysaccharide (LPS) stimulated monocytes/alveolar macrophages (AM)." | 1.32 | [Inhibition of cytokine release from alveolar macrophages in pulmonary sarcoidosis by pentoxifylline]. ( Chen, BM; Costabel, U; Dai, HP; Guzman, J; Tong, ZH; Wang, C, 2003) |
| "Pentoxifylline (POF) has been shown to suppress the cytokine production from lipopolysaccharide (LPS)-stimulated monocytes/alveolar macrophages (AMs)." | 1.32 | Inhibition of cytokine release from alveolar macrophages in pulmonary sarcoidosis by pentoxifylline: comparison with dexamethasone. ( Abdoh, Z; Chen, B; Costabel, U; Dai, H; Guzman, J; Tong, Z, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 5 (62.50) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bargagli, E | 1 |
| Olivieri, C | 1 |
| Rottoli, P | 1 |
| Mrazek, F | 1 |
| Sekerova, V | 1 |
| Drabek, J | 1 |
| Kolek, V | 1 |
| du Bois, RM | 1 |
| Petrek, M | 1 |
| Tong, ZH | 1 |
| Dai, HP | 1 |
| Chen, BM | 1 |
| Wang, C | 1 |
| Guzman, J | 3 |
| Costabel, U | 3 |
| Tong, Z | 1 |
| Dai, H | 1 |
| Chen, B | 1 |
| Abdoh, Z | 1 |
| Inoue, K | 1 |
| Takano, H | 1 |
| Yanagisawa, R | 1 |
| Sakurai, M | 1 |
| Paramothayan, S | 1 |
| Lasserson, TJ | 1 |
| Walters, EH | 1 |
| Zabel, P | 1 |
| Entzian, P | 1 |
| Dalhoff, K | 1 |
| Schlaak, M | 1 |
| Marques, LJ | 1 |
| Zheng, L | 1 |
| Poulakis, N | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Treatment of Pulmonary Sarcoidosis With Pentoxifylline[NCT00001877] | Phase 2 | 100 participants | Interventional | 1999-02-28 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for pentoxifylline and Pulmonary Sarcoidosis
| Article | Year |
|---|---|
Cytokine modulators in the treatment of sarcoidosis.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; C | 2011 |
Immunosuppressive and cytotoxic therapy for pulmonary sarcoidosis.
Topics: Antineoplastic Agents; Chloroquine; Cyclosporine; Humans; Immunosuppressive Agents; Methotrexate; Pe | 2006 |
6 other studies available for pentoxifylline and Pulmonary Sarcoidosis
| Article | Year |
|---|---|
Expression of the chemokine PARC mRNA in bronchoalveolar cells of patients with sarcoidosis.
Topics: Adjuvants, Immunologic; Adult; Aged; Base Sequence; Bronchoalveolar Lavage Fluid; Cell Count; Chemok | 2002 |
[Inhibition of cytokine release from alveolar macrophages in pulmonary sarcoidosis by pentoxifylline].
Topics: Adult; Cytokines; Dexamethasone; Female; Humans; Lipopolysaccharides; Macrophages, Alveolar; Male; M | 2003 |
Inhibition of cytokine release from alveolar macrophages in pulmonary sarcoidosis by pentoxifylline: comparison with dexamethasone.
Topics: Adult; Anti-Inflammatory Agents; Cytokines; Dexamethasone; Female; Humans; Macrophages, Alveolar; Ma | 2003 |
Anti-inflammatory Effect of Pentoxifylline.
Topics: Anti-Inflammatory Agents; Cytokines; Humans; Immunity, Cellular; Pentoxifylline; Sarcoidosis, Pulmon | 2004 |
Pentoxifylline in treatment of sarcoidosis.
Topics: Adult; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Male; Pentoxifylline; Phosphodies | 1997 |
Pentoxifylline inhibits TNF-alpha production from human alveolar macrophages.
Topics: Adult; Biomarkers; Cells, Cultured; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent As | 1999 |